Tenshi Pharmaceuticals Private Limited, a promoter entity of OneSource Specialty Pharma, has acquired 200,000 equity shares from the market on January 28, 2026. This purchase represents approximately 0.17% of OneSource Specialty Pharma’s equity share capital. The disclosure was made under regulations related to substantial acquisition of shares and insider trading.
Stake Acquisition by Promoter
Tenshi Pharmaceuticals Private Limited, a promoter entity of OneSource Specialty Pharma Limited, has increased its stake in the company. The acquisition involved the purchase of 200,000 equity shares on January 28, 2026, through market transactions.
Details of the Transaction
The acquired shares represent 0.17% of the total equity share capital of OneSource Specialty Pharma Limited. Post-acquisition, the promoter group’s shareholding has increased to 3,44,96,199 shares, representing 30.10% of the total shareholding, as per the details provided in the disclosure.
Promoter Group Holdings
The promoter and promoter group’s holdings before the acquisition were 3,42,96,199 shares, constituting 29.93% of the total equity. The acquisition of 200,000 shares has led to a corresponding increase in their overall stake.
Source: BSE
